These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 23771511)
1. Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. Berntsson SG; Falk A; Savitcheva I; Godau A; Zetterling M; Hesselager G; Alafuzoff I; Larsson EM; Smits A J Neurooncol; 2013 Sep; 114(2):241-9. PubMed ID: 23771511 [TBL] [Abstract][Full Text] [Related]
2. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531 [TBL] [Abstract][Full Text] [Related]
3. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832 [TBL] [Abstract][Full Text] [Related]
4. Glioma grading by dynamic susceptibility contrast perfusion and Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Reischl G; Bender B; Ernemann U; la Fougère C; Klose U Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269 [TBL] [Abstract][Full Text] [Related]
5. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging. Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
7. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading. Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406 [TBL] [Abstract][Full Text] [Related]
8. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement. Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors. Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243 [TBL] [Abstract][Full Text] [Related]
10. Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice. Dandois V; Rommel D; Renard L; Jamart J; Cosnard G J Neuroradiol; 2010 May; 37(2):89-97. PubMed ID: 19570578 [TBL] [Abstract][Full Text] [Related]
11. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas]. Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188 [TBL] [Abstract][Full Text] [Related]
12. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706 [TBL] [Abstract][Full Text] [Related]
13. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643 [TBL] [Abstract][Full Text] [Related]
14. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957 [TBL] [Abstract][Full Text] [Related]
15. Non-invasive assessment of heterogeneity of gliomas using diffusion and perfusion MRI: correlation with spatially co-registered PET. Zhang Y; Lin Y; Xing Z; Yao S; Cao D; Miao WB Acta Radiol; 2022 May; 63(5):664-671. PubMed ID: 33858207 [TBL] [Abstract][Full Text] [Related]
16. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
17. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
18. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas. Collet S; Valable S; Constans JM; Lechapt-Zalcman E; Roussel S; Delcroix N; Abbas A; Ibazizene M; Bernaudin M; Barré L; Derlon JM; Guillamo JS Neuroimage Clin; 2015; 8():448-54. PubMed ID: 26106569 [TBL] [Abstract][Full Text] [Related]